Submission of documentation for single technology assessment of pharmaceuticals

Published: 10/10/2023

Changes

All new pharmaceuticals with Marketing Authorisation are subject to a single technology assessment (STA) before they can be publicly funded either by the Regional Health Authorities (Nye metoder) or under the National Insurance Scheme (folketrygden).

Frequently used pages

Submission of documentation for single technology assessment of pharmaceuticals
Template for submission of documentation for the single technology assessment of pharmaceuticals

Contact us

Unit for HTA and general reimbursement

22 89 77 00

blaresept@noma.no

Unit for HTA hospital medicines

22 89 77 00

sykehus@noma.no

Did you find what you were looking for?

Describe what you did not find

0/255 characters

I confirm that I do not submit any personal information, e.g. name, telephone number or email address.